| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. | Director | Common Stock, $.0001 par value | 18,555 | $39,707 | $2.14 | 11 Sep 2025 | Direct |
| Xenetic Biosciences, Inc. | Chief Sciencific Officer | Stock Options | 10,000 | 11 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | 11 Sep 2025 | 1 | $0 | 4 | Director | 15 Sep 2025, 08:29 |
| PHIO | Phio Pharmaceuticals Corp. | 11 Sep 2024 | 1 | $0 | 4 | Director | 12 Sep 2024, 16:11 |
| XBIO | Xenetic Biosciences, Inc. | 11 Dec 2023 | 1 | $0 | 4 | Chief Sciencific Officer | 13 Dec 2023, 17:30 |
| PHIO | Phio Pharmaceuticals Corp. | 17 Feb 2023 | 1 | $0 | 4 | Director | 22 Feb 2023, 18:30 |
| XBIO | Xenetic Biosciences, Inc. | 24 Mar 2022 | 1 | $0 | 4 | Chief Sciencific Officer | 28 Mar 2022, 17:13 |
| PHIO | Phio Pharmaceuticals Corp. | 15 Feb 2022 | 1 | $0 | 4 | Director | 16 Feb 2022, 19:12 |